We are live on ! Find out more
WST icon

West Pharmaceutical

197 hedge funds and large institutions have $2.19B invested in West Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 197 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

180.46% more ownership

Funds ownership: 0%180.46% (+180%)

Holders
197
Holders Change
+197
Holders Change %
% of All Funds
6.43%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
197
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
IPC
151
Independent Portfolio Consultants
Florida
$441K +$413K +12,560 New
AI
152
Analytic Investors
California
$413K +$387K +11,758 New
GT
153
Glenmede Trust
Pennsylvania
$400K +$375K +11,400 New
OA
154
OFI Advisors
Pennsylvania
$373K +$349K +10,616 New
KCG
155
Knight Capital Group
$359K +$336K +10,218 New
MSA
156
Mason Street Advisors
Wisconsin
$337K +$315K +9,584 New
Los Angeles Capital Management
157
Los Angeles Capital Management
California
$329K +$309K +9,378 New
Tudor Investment Corp
158
Tudor Investment Corp
Connecticut
$323K +$303K +9,200 New
WAM
159
World Asset Management
Michigan
$318K +$298K +9,060 New
GCP
160
GSA Capital Partners
United Kingdom
$309K +$290K +8,802 New
GC
161
Guggenheim Capital
Illinois
$287K +$269K +8,174 New
SB
162
Suntrust Banks
Georgia
$286K +$269K +8,176 New
AG
163
Aperio Group
California
$277K +$259K +7,874 New
PI
164
PineBridge Investments
New York
$276K +$258K +7,848 New
CCMG
165
Clark Capital Management Group
Pennsylvania
$270K +$253K +7,676 New
BIM
166
Bridgecreek Investment Management
Oklahoma
$267K +$250K +7,600 New
AAM
167
Azzad Asset Management
Virginia
$255K +$408K +12,412 New
PIM
168
Penobscot Investment Management
Massachusetts
$254K +$238K +7,220 New
PP
169
Paloma Partners
Connecticut
$211K +$198K +6,006 New
JFGIW
170
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$209K +$196K +5,950 New
FMBTD
171
First Midwest Bank Trust Division
Illinois
$209K +$196K +5,962 New
DC
172
Deere & Company
Illinois
$207K +$194K +5,906 New
Envestnet Asset Management
173
Envestnet Asset Management
Illinois
$196K +$183K +5,576 New
HNB
174
Huntington National Bank
Ohio
$183K +$171K +5,200 New
Teacher Retirement System of Texas
175
Teacher Retirement System of Texas
Texas
$164K +$154K +4,680 New

WST Hedge Fund Activity: Q2 2013 in Review

197 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2013, worth a combined $2.19B.

Buyers outnumbered sellers: 197 funds opened new WST positions and 0 closed out — a net gain of 197 holders — while 0 added to existing stakes and 0 trimmed.

  • 197 institutional investors held West Pharmaceutical (WST) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.19B of West Pharmaceutical stock for Q2 2013.
  • 197 funds opened new West Pharmaceutical positions in Q2 2013 and 0 closed out, a net change of +197 holders.

Based on aggregated 13F filings for Q2 2013.